In stock
TCI Blend 12mg Snap Pen
฿5,888
In stock
Specifications:
- 0.12mg per click
- Up to 60 clicks per dose.
TCI Blend Snap Pen (Tesamorelin + CJC-1295 (No DAC) + Ipamorelin)
Growth Hormone Modulation, Metabolic Support & Recovery Optimization
TCI Blend is a synergistic peptide formulation combining Tesamorelin, CJC-1295 (No DAC), and Ipamorelin—three peptides that work together to support endogenous growth hormone signaling, metabolic balance, tissue maintenance, and recovery pathways.
By integrating a long-acting GHRH analog (Tesamorelin) with a short-acting GHRH analog (CJC-1295 No DAC) and a selective ghrelin receptor agonist (Ipamorelin), TCI Blend is designed to stimulate physiological, pulsatile GH release through multiple complementary mechanisms..
Peptide Composition
- Tesamorelin — A stabilized Growth Hormone Releasing Hormone (GHRH) analog associated with endogenous GH stimulation and metabolic signalling.
- CJC-1295 (No DAC) — A Growth Hormone Releasing Hormone (GHRH) analog that promotes pulsatile GH release.
- Ipamorelin — A selective ghrelin receptor agonist that stimulates GH release without significantly affecting cortisol or prolactin.
Combined peptide activity supports cellular recovery and metabolic adaptation.
Key Potential Benefits*
- Optimized Growth Hormone Output — Encourages natural GH and IGF-1 signaling.
- Improved Recovery & Adaptation — Facilitates faster recovery following physical stress or training.
- Growth Hormone Optimization — Encourages natural GH release and downstream IGF-1 activity.
- Lean Mass & Body Composition Support — GH-mediated pathways contribute to improved muscle and fat metabolism.
- Synergistic Multi-Pathway Action — Combines regenerative and endocrine pathways in one formulation.
* as indicated in medical trials.
Technical Information
CAS Number: | 218949-48-5 / 863288-34-0 / 170851-70-4 |
PubChem CID: | 19243281 / 25285409 / 10382169 |
Formula: | C₂₂₁H₃₆₆N₇₂O₆₇/ C₁₅₂H₂₅₂N₄₄O₄₂ / C₃₈H₄₉N₉O₅ |
Synonyms: | Tesamorelin, 218949-48-5, Egrifta, Growth Hormone Releasing Hormone analog, GHRH (1–44) acetate, stabilized GHRH peptide
CJC-1295 (No DAC), CJC 1295 No DAC, Modified GRF (1-29), Mod GRF 1-29, 863288-34-0, Growth Hormone Releasing Hormone analog, GHRH analog Ipamorelin, IPA, NNC 26-0161, 170851-70-4, Growth Hormone Secretagogue, Ghrelin receptor agonist, GHS-R1a agonist |